Dorhout Mees E J, Geyskes G G, Vos J, Boer P
Arch Int Pharmacodyn Ther. 1975 Apr;214(2):335-46.
Reduction of the (expanded) body fluid volumes found in some patients with renal hypertension may be essential in the management of these cases. Illustrative examples are given of this "volume dependent" form of hypertension. In such patients, plasma renin activity (PRA) is low. Other forms of hypertension may be regarded as caused by "inappropriate renin secretion". Most often, however, both factors are operative. This concept is supported by experimental evidence obtained in animals. The combined effect of salt depletion (which increases PRA) and beta-adrenergic blockade with propranolol (during which treatment PRA is lowered) was systematically studied in 3 groups of hypertensive patients (including one group with chronic renal insufficiency). The results indicate that this combined therapy lowers the blood pressure in various types of hypertension, the effect being sometimes more than additive. There was, however, no correlation between the PRA levels and the blood pressure decrease after salt depletion or after propranolol. Consequently, on the basis of the PRA values, no group of patients could be identified for which this treatment would be specifically indicated.
减少某些肾性高血压患者体内(扩张的)体液量,对于这些病例的治疗可能至关重要。文中给出了这种“容量依赖性”高血压形式的示例。在此类患者中,血浆肾素活性(PRA)较低。其他形式的高血压可能被认为是由“肾素分泌不当”引起的。然而,大多数情况下,这两个因素都起作用。这一概念得到了在动物身上获得的实验证据的支持。对三组高血压患者(包括一组慢性肾功能不全患者)系统研究了限盐(可增加PRA)和使用普萘洛尔进行β-肾上腺素能阻滞(治疗期间PRA降低)的联合效应。结果表明,这种联合治疗可降低各类高血压患者的血压,其效果有时大于两者单独作用之和。然而,PRA水平与限盐后或普萘洛尔治疗后的血压下降之间并无相关性。因此,根据PRA值,无法确定哪组患者适合这种特定的治疗方法。